Controlling stereoselectivity by enzymatic and chemical means to access enantiomerically pure (1S,3R)-1-benzyl-2,3-dimethyl-1,2,3,4-tetrahydroisoquinoline derivatives

Add time:09/01/2019    Source:sciencedirect.com

A chemoenzymatic strategy for the synthesis of enantiomerically pure novel alkaloids (1S,3R)-1-benzyl-2,3-dimethyl-1,2,3,4-tetrahydroisoquinolines is presented. The key steps are the biocatalytic stereoselective reductive amination of substituted 1-phenylpropan-2-one derivatives to yield chiral amines employing microbial ω-transaminases, and the diastereoselective reduction of a Bischler–Napieralski imine intermediate by catalytic hydrogenation in the presence of palladium on charcoal, leading exclusively to the desired cis-isomer.

We also recommend Trading Suppliers and Manufacturers of 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4). Pls Click Website Link as below: cas 19716-56-4 suppliers

Prev:1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4) passes through the blood–brain barrier of rat brain: An in vivo microdialysis study
Next:Short communicationNo reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE (cas 19716-56-4))